These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7821305)

  • 21. Poor oral health is associated with coronary heart disease and elevated systemic inflammatory and haemostatic factors.
    Montebugnoli L; Servidio D; Miaton RA; Prati C; Tricoci P; Melloni C
    J Clin Periodontol; 2004 Jan; 31(1):25-9. PubMed ID: 15058371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symptoms of chronic bronchitis, haemostatic factors, and coronary heart disease risk.
    Jousilahti P; Salomaa V; Rasi V; Vahtera E
    Atherosclerosis; 1999 Feb; 142(2):403-7. PubMed ID: 10030392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of haemostatic risk factors for coronary heart disease in obese children and adolescents.
    Gallistl S; Sudi KM; Borkenstein M; Troebinger M; Weinhandl G; Muntean W
    Int J Obes Relat Metab Disord; 2000 Nov; 24(11):1459-64. PubMed ID: 11126343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood coagulation and fibrinolysis in obese NIDDM patients.
    Avellone G; Di Garbo V; Cordova R; Rotolo G; Abruzzese G; Raneli G; De Simone R; Bompiani GD
    Diabetes Res; 1994; 25(2):85-92. PubMed ID: 7648783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations of plasma fibrinogen and factor VII clotting activity with coronary heart disease and stroke: prospective cohort study from the screening phase of the Thrombosis Prevention Trial.
    Rudnicka AR; Mt-Isa S; Meade TW
    J Thromb Haemost; 2006 Nov; 4(11):2405-10. PubMed ID: 17002654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.
    Meade TW; Mellows S; Brozovic M; Miller GJ; Chakrabarti RR; North WR; Haines AP; Stirling Y; Imeson JD; Thompson SG
    Lancet; 1986 Sep; 2(8506):533-7. PubMed ID: 2875280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HDL cholesterol predicts coronary heart disease mortality in older persons.
    Corti MC; Guralnik JM; Salive ME; Harris T; Field TS; Wallace RB; Berkman LF; Seeman TE; Glynn RJ; Hennekens CH
    JAMA; 1995 Aug; 274(7):539-44. PubMed ID: 7629981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors].
    Nogués X; Sentí M; Pedro-Botet J; Molina L; Serrat R; Pons S; Rubiés-Prat J
    Med Clin (Barc); 1992 Feb; 98(5):171-4. PubMed ID: 1532436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haemostatic and other cardiovascular risk factors, and socioeconomic status among middle-aged Finnish men and women.
    Myllykangas M; Pekkanen J; Rasi V; Haukkala A; Vahtera E; Salomaa V
    Int J Epidemiol; 1995 Dec; 24(6):1110-6. PubMed ID: 8824851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy].
    Saitta A; Castaldo M; Sardo A; Cinquegrani M; Bonaiuto M; Zema M; Gravina M; Mangano C
    Minerva Med; 1999; 90(5-6):151-8. PubMed ID: 10780189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease.
    Imhof A; Rothenbacher D; Khuseyinova N; Hoffmeister A; Maerz W; Nauck M; Scharnagl H; Koenig W; Brenner H
    Eur J Cardiovasc Prev Rehabil; 2003 Oct; 10(5):362-70. PubMed ID: 14663298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High intakes of trans monounsaturated fatty acids taken for 2 weeks do not influence procoagulant and fibrinolytic risk markers for CHD in young healthy men.
    Sanders TA; Oakley FR; Crook D; Cooper JA; Miller GJ
    Br J Nutr; 2003 Jun; 89(6):767-76. PubMed ID: 12828793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Socioeconomic status and determinants of hemostatic function in healthy women.
    Wamala SP; Murray MA; Horsten M; Eriksson M; Schenck-Gustafsson K; Hamsten A; Silveira A; Orth-Gomér K
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):485-92. PubMed ID: 10073947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier?
    Shai I; Rimm EB; Hankinson SE; Cannuscio C; Curhan G; Manson JE; Rifai N; Stampfer MJ; Ma J
    Eur Heart J; 2005 Aug; 26(16):1633-9. PubMed ID: 15824077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-HDL cholesterol predicts coronary heart disease in primary prevention: findings from an Italian 40-69 year-old cohort in general practice.
    Ciardullo AV; Azzolini L; Bevini M; Cadioli T; Malavasi P; Morellini A; Daghio MM; Guidetti P; Lorenzetti M; Carapezzi C; Bacchelli M; Bellodi C; Beltrami AC; Carretti G; Di Fiore A; Feltri G; Frigani A; Gaglianò G; Gazzani G; Loscalzo G; Losi A; Mantovani L; Pavarotti V; Prandi B; Ribaldi A; Rosselli C; Tirelli G; Veratti M; Vincenzi A;
    Monaldi Arch Chest Dis; 2004 Jun; 62(2):69-72. PubMed ID: 15552218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary Low Level of High-Density Lipoprotein Cholesterol and Risks of Coronary Heart Disease, Cardiovascular Disease, and Death: Results From the Multi-Ethnic Study of Atherosclerosis.
    Ahmed HM; Miller M; Nasir K; McEvoy JW; Herrington D; Blumenthal RS; Blaha MJ
    Am J Epidemiol; 2016 May; 183(10):875-83. PubMed ID: 27189327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of lipoprotein(a) levels and myocardial stress thallium scintigraphy pattern in different entities of CHD severity.
    Palumbo B; Lupattelli G; Siepi D; Bianchi A; Anniboletti PF; Blandini V; Sinzinger H; Mannarino E; Palumbo R
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):987-91. PubMed ID: 12635466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-sectional study of complement C3 as a coronary risk factor among men and women.
    Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V
    Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: the atherosclerosis risk in communities study.
    Muntner P; Lee F; Astor BC
    Am J Med Sci; 2011 Mar; 341(3):173-80. PubMed ID: 21042169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.